Canada Life’s Rigel Pharmaceuticals RIGL Stock Holding History

Canada Life’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,923	Closed	-$93K	–	2377
2022 Q3	$93K	Buy	7,923 +7,036	+793%	+$95.2K	﹤0.01%	1999
2022 Q2	$10K	Hold	887	–	–	﹤0.01%	2365
2022 Q1	$28K	Hold	887	–	–	﹤0.01%	2291
2021 Q4	$23K	Hold	887	–	–	﹤0.01%	2348
2021 Q3	$32K	Hold	887	–	–	﹤0.01%	2345
2021 Q2	$38K	Hold	887	–	–	﹤0.01%	2345
2021 Q1	$30K	Hold	887	–	–	﹤0.01%	2445
2020 Q4	$31K	Hold	887	–	–	﹤0.01%	2448
2020 Q3	$21K	Hold	887	–	–	﹤0.01%	2433
2020 Q2	$16K	Hold	887	–	–	﹤0.01%	2530
2020 Q1	$14K	Hold	887	–	–	﹤0.01%	2449
2019 Q4	$19K	Buy	+887	New	+$18.3K	﹤0.01%	2510
2019 Q3	–	Sell	-1,671	Closed	-$43K	–	2024
2019 Q2	$43K	Hold	1,671	–	–	﹤0.01%	2479
2019 Q1	$42K	Hold	1,671	–	–	﹤0.01%	2293
2018 Q4	$37K	Hold	1,671	–	–	﹤0.01%	2459
2018 Q3	$54K	Hold	1,671	–	–	﹤0.01%	2376
2018 Q2	$47K	Hold	1,671	–	–	﹤0.01%	2414
2018 Q1	$59K	Hold	1,671	–	–	﹤0.01%	2329
2017 Q4	$65K	Buy	+1,671	New	+$63.6K	﹤0.01%	2290
2014 Q4	–	Sell	-445	Closed	-$9K	–	2569
2014 Q3	$9K	Hold	445	–	–	﹤0.01%	2403
2014 Q2	$16K	Hold	445	–	–	﹤0.01%	2269
2014 Q1	$17K	Hold	445	–	–	﹤0.01%	2156
2013 Q4	$13K	Buy	+445	New	+$13.1K	﹤0.01%	2180

Other funds holding RIGL

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Canada Life's RIGL Position: Q4 2022 in Review

Canada Life sold out of Rigel Pharmaceuticals (RIGL) in Q4 2022, closing a stake of 7,923 shares — an estimated $93K sold.

Canada Life first reported a position in RIGL in Q4 2013 and held it in 23 quarters. The position peaked at $93K in Q3 2022. 118 funds tracked by Wall St. Rank hold RIGL as of Q4 2022.

Canada Life reported no remaining Rigel Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Canada Life sold 7,923 Rigel Pharmaceuticals shares in Q4 2022, an estimated $93K.
Canada Life first reported a position in Rigel Pharmaceuticals in Q4 2013 and held it in 23 quarters.
Canada Life's Rigel Pharmaceuticals position peaked at $93K in Q3 2022.
118 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2022.

Based on Canada Life's 13F filing for Q4 2022, filed 10 Feb 2023.